Bolt Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 07, 2023 at 04:09 pm EDT
Bolt Biotherapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 18.06 million compared to USD 22.66 million a year ago. Basic loss per share from continuing operations was USD 0.48 compared to USD 0.61 a year ago.
For the six months, net loss was USD 35.04 million compared to USD 46.34 million a year ago. Basic loss per share from continuing operations was USD 0.93 compared to USD 1.25 a year ago.